Elevance Health Inc. (ELV): ANSOFF MATRIX ANÁLISE [JAN-2025 Atualizado]

No cenário dinâmico da inovação em saúde, a Elevance Health Inc. (ELV) está pronta para redefinir o crescimento estratégico por meio de uma matriz abrangente de Ansoff que transcende os limites tradicionais de seguro. Ao elaborar meticulosamente estratégias de penetração de mercado, desenvolvimento de mercado, desenvolvimento de produtos e diversificação, a empresa está se posicionando como uma força transformadora na prestação de serviços de saúde. Desde a expansão das ofertas do Medicare Advantage até as avaliações de risco à saúde de IA pioneiras, a Saúde da Elevance demonstra um compromisso sem precedentes com soluções de saúde personalizadas e orientadas por tecnologia que prometem remodelar como indivíduos e comunidades experimentam serviços médicos.

Elevance Health Inc. (ELV) - Ansoff Matrix: Penetração de mercado

Expanda Ofertas de Plano de Plano de Vantagem do Medicare em regiões geográficas existentes

A Elevance Health reportou 1,5 milhão de membros do Medicare Advantage no quarto trimestre 2022. A empresa expandiu a cobertura do Medicare Advantage para 14 municípios adicionais em 2022. A associação ao Medicare Advantage cresceu 8,3% ano a ano.

Métrico do Medicare Advantage	2022 dados
Membros do Total Medicare Advantage	1,5 milhão
Novas expansões do condado	14 municípios
Crescimento ano a ano	8.3%

Aumentar o envolvimento da saúde digital por meio de recursos aprimorados de aplicativos móveis

A plataforma digital da Elevance Health reportou 3,2 milhões de usuários ativos de aplicativos móveis em 2022. O envolvimento de aplicativos móveis aumentou 22% em comparação com 2021.

• 3,2 milhões de usuários ativos de aplicativos móveis
• Aumento de 22% no engajamento da plataforma digital
• Mais de 75% dos membros acessaram os serviços de telessaúde em 2022

Implementar campanhas de marketing direcionadas para atrair mais assinantes individuais e em grupo

A Elevance Health investiu US $ 127 milhões em despesas de marketing em 2022. A participação no mercado individual aumentou 6,5% durante o mesmo período.

Métrica de marketing	2022 dados
Despesas de marketing	US $ 127 milhões
Crescimento individual do mercado	6.5%

Aprimore os programas de retenção de clientes com serviços de gerenciamento de saúde personalizados

A taxa de retenção de clientes atingiu 87,4% em 2022. Programas de gerenciamento de cuidados personalizados cobriam 1,1 milhão de membros.

• 87,4% da taxa de retenção de clientes
• 1,1 milhão de membros em programas de gerenciamento de cuidados personalizados
• US $ 92 milhões investidos em melhorias na experiência do cliente

Otimize estratégias de preços para atrair mais consumidores de saúde consciente de custos

A Elevance Health introduziu 15 novos planos de saúde de baixo custo em 2022. Redução média de prêmio de 4,2% para planos de mercado individuais.

Métrica de Estratégia de Preços	2022 dados
Novos planos de saúde de baixo custo	15 planos
Redução média de prêmio	4.2%

Elevance Health Inc. (ELV) - Ansoff Matrix: Desenvolvimento de Mercado

Expanda para novos mercados estaduais de saúde com linhas de produtos de seguros atuais

A Saúde da Elevance opera em 14 estados a partir de 2023, com um plano estratégico para expandir para mercados adicionais. A receita de 2022 da empresa atingiu US $ 171,8 bilhões, indicando potencial para o crescimento do mercado geográfico.

Estado	Presença atual do mercado	Potencial de expansão
Califórnia	Mercado ativo	Alto potencial de expansão
Flórida	Presença limitada	Potencial de expansão moderada
Texas	Mercado emergente	Alto potencial de expansão

Target Mercados de saúde rural mal atendidos com soluções de seguro personalizado

Os mercados de saúde rural representam 15% da população total dos EUA, com aproximadamente 46 milhões de indivíduos residentes nessas áreas.

• Penetração de seguro de mercado rural: 62%
• Gastos médios de saúde rural: US $ 8.200 per capita
• Tamanho potencial do mercado: US $ 377,2 milhões

Desenvolva parcerias estratégicas com provedores regionais de saúde em novas áreas geográficas

Atualmente, a Elevance Health mantém 68.000 parcerias de prestadores de serviços de saúde nos mercados existentes.

Tipo de parceria	Número de parcerias	Investimento anual
Redes hospitalares	1,200	US $ 45,6 milhões
Grupos médicos	42,500	US $ 78,3 milhões
Centros de atendimento especializado	24,300	US $ 32,7 milhões

Explore a expansão potencial para os mercados emergentes de serviços de telessaúde

O mercado de telessaúde projetou atingir US $ 185,6 bilhões até 2026, com uma taxa de crescimento anual composta de 23,5%.

• Taxa atual de adoção de telessaúde: 38%
• Base potencial de pacientes com telessaúde: 124 milhões de indivíduos
• Potencial estimado de receita de telessaúde: US $ 42,3 bilhões

Aumentar a presença em estados com a crescente demografia da população sênior

A população sênior (mais de 65 anos) deve atingir 73,1 milhões até 2030, representando uma oportunidade significativa de mercado.

Estado	População sênior	Penetração de mercado
Flórida	4,6 milhões	21.3%
Arizona	1,2 milhão	16.7%
Califórnia	5,7 milhões	14.5%

Elevance Health Inc. (ELV) - Ansoff Matrix: Desenvolvimento do Produto

Lançar programas inovadores de monitoramento e bem -estar da saúde digital

A Elevance Health investiu US $ 287 milhões em tecnologia de saúde digital em 2022. Sua plataforma de saúde digital atende a 17,3 milhões de membros por meio de aplicativos móveis integrados.

Métricas de saúde digital	2022 dados
Usuários de aplicativos móveis	4,6 milhões
Interações de telessaúde	23,4 milhões
Pacientes de monitoramento remoto	892,000

Desenvolver produtos de seguro especializados para gerenciamento de doenças crônicas

A Elevance Health desenvolveu 12 programas especializados de gerenciamento de doenças crônicas que cobrem diabetes, doenças cardíacas e cuidados com o câncer.

• Programa de gerenciamento de diabetes: 345.000 pacientes inscritos
• Programa de Cuidados Cardiovasculares: 276.000 participantes
• Rede de suporte oncológica: 214.000 membros

Crie opções personalizadas de medicina de precisão e saúde genômica

Os investimentos genômicos de saúde atingiram US $ 42,5 milhões em 2022, cobrindo testes genéticos para 129.000 membros.

Serviços de Medicina de Precisão	Métricas de cobertura
Cobertura de testes genéticos	129.000 membros
Planos de tratamento personalizados	84.500 pacientes

Introduzir pacotes de seguro integrados de saúde mental e bem -estar comportamental

O investimento do Programa de Saúde Mental totalizou US $ 93,7 milhões em 2022, servindo 512.000 membros.

• Sessões de Teleterapia: 1,3 milhão em 2022
• Programas de triagem de saúde mental: 437.000 participantes
• Coaching de saúde comportamental: 276.000 membros

Desenvolver ferramentas de avaliação de risco de saúde preditiva movida a IA

O investimento em tecnologia da IA ​​atingiu US $ 64,2 milhões, com ferramentas preditivas de avaliação de risco cobrindo 8,9 milhões de membros.

Métricas de avaliação de risco à saúde da IA	2022 Performance
Precisão da previsão de risco de IA	87.3%
Membros cobertos	8,9 milhões
Casos de intervenção precoce	42,600

Elevance Health Inc. (ELV) - Ansoff Matrix: Diversificação

Invista em startups de tecnologia de saúde com modelos de serviço complementares

Em 2022, a Elevance Health investiu US $ 127 milhões em empreendimentos de startups de saúde digital. O ARM de capital de risco da Companhia, Elevance Venture Partners, concentrou -se em 7 plataformas específicas de tecnologia de saúde.

Categoria de investimento	Investimento total	Número de startups
Plataformas de saúde digital	US $ 127 milhões	7 startups
Tecnologias de telessaúde	US $ 42 milhões	3 startups

Desenvolver redes clínicas de atenção primária direta

A Elevance Health expandiu sua rede direta de cuidados primários para 134 clínicas em 12 estados, atendendo a aproximadamente 218.000 pacientes em 2022.

• Total de Clínicas: 134
• Estados cobertos: 12
• Base de pacientes: 218.000

Criar plataformas abrangentes de bem -estar e gerenciamento preventivo de saúde

A empresa investiu US $ 93 milhões no desenvolvimento de plataformas de bem -estar integradas com Análise de Saúde preditiva orientada pela IA.

Componente da plataforma	Investimento	Engajamento do usuário
Analítica de bem -estar	US $ 93 milhões	372.000 usuários ativos

Explore Oportunidades Internacionais de Mercado de Seguros de Saúde

A Elevance Health iniciou a expansão do mercado internacional, visando três novos países com investimentos projetados de entrada no mercado de US $ 64 milhões.

• Países direcionados: 3
• Investimento de entrada no mercado: US $ 64 milhões
• Receita internacional projetada: US $ 142 milhões até 2025

Desenvolver serviços de análise de dados e gerenciamento de saúde da população

A empresa alocou US $ 86 milhões para o desenvolvimento de serviços avançados de consultoria em gestão de saúde da população.

Categoria de serviço	Investimento	Receita projetada
Data Analytics Consulting	US $ 86 milhões	US $ 215 milhões até 2024

Elevance Health Inc. (ELV) - Ansoff Matrix: Market Penetration

Market Penetration for Elevance Health Inc. (ELV) centers on deepening relationships and increasing share within its existing member base and core markets. This strategy relies on enhancing current product value and driving utilization of integrated services.

For Medicare Advantage (MA), the focus is on retaining and growing the existing pool of enrollees through better offerings. Elevance Health executives expressed confidence in achieving a 7% to 9% growth target in MA membership for the full year 2025. This follows a period of net gains, with Elevance Health adding about 249,000 MA beneficiaries between March 2024 and March 2025. As of the first quarter of 2025, the company reported total medical membership of approximately 45.8 million, with MA growth being a key driver. The February 2025 enrollment figure for MA stood at 2,285,070 members, up from just over 2 million at the end of 2024.

Driving digital engagement is crucial for retention in the Commercial segment. While a specific adoption percentage target wasn't confirmed, the broader digital strategy is backed by a concrete financial goal: Elevance Health aims to achieve $1 billion in annual revenue from digital solutions by 2025. This push for digital utility supports the overall goal of improving member experience and reducing churn.

To improve pricing competitiveness and manage costs, expanding provider-payer collaboration models directly impacts the Medical Loss Ratio (MLR). The MLR for the second quarter of 2025 was reported at 88.9%, which is higher than the first quarter's 86.4%. The projection for the full year 2025 MLR is 89.1% +/- 50 bps. Successfully reducing this ratio through better care coordination allows for more competitive pricing in the market.

The push to offer bundled benefits to small businesses is captured within the performance of the Health Benefits segment, which includes commercial lines. For the second quarter of 2025, this segment reported operating revenue of $41.6 billion. The success of integrating services, like those under the Carelon brand, is evident in the services segment's growth, which supports the value proposition for all member groups.

The conversion of existing Blue Cross Blue Shield members to Elevance Health's Carelon services is part of a broader strategy to scale the Health Services arm. Carelon's performance shows strong adoption of its integrated offerings. Operating revenue for Carelon reached $18.3 billion in the third quarter of 2025, marking a 33% increase compared to the prior year quarter. In the first quarter of 2025, Carelon operating revenue was $16.7 billion, a 38% year-over-year increase.

Here's a look at key financial and operational metrics related to these Market Penetration activities in 2025:

Metric	Latest Reported Figure (2025)	Context/Period
Total Medical Membership	45.4 million to 45.8 million	Q1 2025 to Q3 2025
Medicare Advantage Membership	2,285,070	February 2025 enrollment
Projected Full Year MA Growth	7% to 9%	2025 Target
Digital Solutions Annual Revenue Goal	$1 billion	2025 Target
Medical Loss Ratio (MLR)	88.9%	Q2 2025
Projected Full Year MLR	89.1% +/- 50 bps	2025 Projection
Carelon Segment Operating Revenue	$18.3 billion	Q3 2025

The strategic actions within this quadrant are designed to maximize the value from the existing customer base, which is reflected in the segment performance:

• Achieved 15.4% operating revenue increase in Q1 2025 to $48.8 billion.
• Health Benefits segment revenue reached $41.6 billion in Q2 2025.
• Carelon segment revenue grew 38% year-over-year in Q1 2025 to $16.7 billion.
• The company returned $2.0 billion of capital to shareholders year-to-date Q2 2025.
• The company had $8.4 billion remaining authorized for share repurchases as of Q1 2025.

Finance: draft Q3 2025 cash flow variance analysis by next Tuesday.

Elevance Health Inc. (ELV) - Ansoff Matrix: Market Development

Enter two new states for Medicaid managed care, aiming for 150,000 new members by year-end.

Elevance Health, Inc. is entering new markets in Florida, Maryland, and Texas in 2025 using its Simply Healthcare and Wellpoint brands. The company expects its full year 2025 Medicaid operating margin to be approximately negative 50 basis points, or modestly below breakeven. Management is planning for at least a 125 basis point year-over-year decline in Medicaid margins for 2026. Total medical membership as of Q2 2025 was approximately 45.6 million, down by about 212,000 from Q1 2025, driven by lower Medicaid membership.

Target the international market for Carelon's digital and behavioral health services, starting with Canada.

Carelon, the health care services arm of Elevance Health, is expanding external relationships and scaling services like behavioral health as an ongoing priority. Carelon Services launched new post-acute and behavioral health contracts, with external growth driven by its scalable whole-person care platform. Carelon's Q3 2025 operating revenue reached $18.3 billion, representing a 33% increase year-over-year. Carelon's Q2 2025 operating revenue was up 36%, or $4.8 billion, to $18.1 billion compared to the year-ago period.

Expand the Federal Employee Program (FEP) offering into new geographic regions currently underserved by ELV.

The number of workers and dependents with coverage through fully insured group plans, Federal Employee Health Benefits Program plans and self-insured employer health plans administered by Elevance increased 1.2%, to 26 million as of year-end 2024. The overall average increase in rates for the FEHB Program for 2025 is 11.2%. The average 2025 biweekly FEHB premium is $694.83.

Acquire a regional health plan to gain immediate scale in a new, high-growth Medicare Advantage market.

Elevance Health projects it will end 2025 with an increase of 7%-9% in Medicare Advantage (MA) membership. The company had just over 2 million MA enrollees out of its 45.7 million total members as of December 2024. Elevance Health is exiting certain underperforming MA plans and counties, which will impact about 150,000 Medicare Advantage members. The company is putting a focus on Medicare Advantage HMO and dual-special needs plans (D-SNP).

Partner with large national employers to offer specialized health plans in states where ELV currently has low penetration.

Elevance Health attracted 18 big, national health plan accounts for 2025. The company also attracted a big employer-sponsored Medicare Advantage retirement plan contract. Elevance Health supports consumers through a diverse portfolio of solutions, serving over 109 million consumers in total across all offerings.

Here are some key financial and statistical metrics for Elevance Health as of or for 2025:

Metric Category	Specific Metric	Value	Period/Context
Financial Guidance	Adjusted Diluted EPS Guidance (Reaffirmed)	Approximately $30.00	Full Year 2025
Financial Performance	Q1 2025 Operating Revenue	$48.8 billion	Q1 2025
Financial Performance	Q3 2025 Operating Revenue	$50.1 billion	Q3 2025
Membership	Total Medical Membership	Approximately 45.8 million	End of Q1 2025
Membership	Projected MA Membership Growth	7%-9% increase	By end of 2025
Segment Performance	Carelon Q3 2025 Operating Revenue	$18.3 billion	Q3 2025
Segment Performance	Health Benefits Operating Revenue	$41.4 billion	Q1 2025
Cost Ratios	Benefit Expense Ratio	86.4%	Q1 2025
Cost Ratios	Medical Loss Ratio (Reported)	88.9%	Q2 2025

You're looking at the Market Development moves Elevance Health is making right now, so here are some of the operational details:

• Elevance Health repurchased 2.2 million shares for $880 million in Q1 2025.
• The company paid a quarterly dividend of $1.71 per share.
• $8.4 billion remained authorized for share repurchases as of Q1 2025.
• The Carelon segment operating gain rose 34% to $1.1 billion in Q1 2025.
• The company expects operating cash flow of approximately $8 billion for 2025.
• The acquisition of CareBridge is expected to generate $1.2 billion in annual revenue by 2026.

Finance: draft 13-week cash view by Friday.

Elevance Health Inc. (ELV) - Ansoff Matrix: Product Development

You're looking at how Elevance Health Inc. (ELV) is developing new products and services to drive growth beyond just selling more of its existing insurance plans. This is about creating new value streams, often through its Carelon services arm.

The push for a new value-based primary care model through Carelon is showing real momentum. For the third quarter of 2025, Carelon revenue hit $18.3 billion, marking a 32.9 percent year-over-year increase, helped by acquisitions and scaling risk-based solutions.

For chronic conditions, the focus is on data integration. In a landmark 12-month randomized clinical trial involving 901 adults with asthma, the Digital Asthma Self-Management (DASM) program showed participants achieved a 4.6-point improvement in Asthma Control Test (ACT) scores, compared to only a 1.8-point improvement in the control group, a 2.8-point gap. Also, for Medicare members with diabetes, value-based care programs drove a 19.2 percent higher rate in better blood sugar control.

In the Commercial segment, new plan designs are being supported by strong underlying performance. For the first quarter of 2025, Commercial membership grew by nearly 600,000 year-over-year. The company reported an Adjusted Diluted Earnings Per Share (EPS) of $11.97 for the first quarter of 2025.

To create a comprehensive mental health and substance use disorder product line, Carelon Behavioral Health already serves over 61.5M+ members across all 50 states, utilizing over 115K+ network providers with a 96 percent in-network utilization rate. For context, Elevance Health's insurance plans claim to cover more than 47.5 million members in the United States.

For post-acute care coordination, the goal is to reduce costly readmissions. Industry data shows the Average Cost of Readmission is $15,200 per patient, and 67 percent of Long-Term Care (LTC) readmissions are avoidable. While a specific 10 percent cost reduction target wasn't found, better management of post-acute care is estimated to reduce costs by 20 to 25 percent.

Here are some of the latest operational metrics supporting these product development efforts:

Metric Category	Specific Data Point	Value
Carelon Revenue (Q3 2025)	Operating Revenue	$18.3 billion
Carelon Growth (YoY)	Revenue Increase	32.9 percent
Chronic Disease Management (Asthma Trial)	ACT Score Improvement Gap	2.8 points
Behavioral Health Scale	Members Served	61.5M+
Commercial Membership Growth (YoY)	Membership Increase	Nearly 600,000
Post-Acute Care Cost Potential	Estimated PAC Cost Reduction Potential	20 to 25 percent

The company is also focused on quality metrics in value-based care. For instance, their complex case management program helped reduce total inpatient admissions by 7 percent for Medicaid members. Also, the care transition interventions program drove reductions in Medicare inpatient admissions by 18 percent.

You should review the capital deployment breakdown, which shows 20 percent is allocated for dividends. Finance: draft 13-week cash view by Friday.

Elevance Health Inc. (ELV) - Ansoff Matrix: Diversification

You're looking at how Elevance Health Inc. could move beyond its core insurance business, which saw trailing twelve-month revenue hit $194.820B as of September 30, 2025, up 11.83% year-over-year. The third quarter 2025 operating revenue alone was $50.1 billion. Diversification here means moving into new markets or offering new services entirely, which is a higher-risk, higher-reward play than just selling more of the same plans.

Acquire a technology firm specializing in large language models (LLMs) for clinical decision support and administrative automation. This aligns with Elevance Health Inc.'s stated focus on advancing its AI and digital strategy, which is a key part of its capital allocation, with 50% of capital earmarked for M&A and organic reinvestment. The Carelon segment, which includes services, already generated $18.3 billion in operating revenue in Q3 2025. Integrating LLMs could directly impact the benefit expense ratio, which Elevance Health Inc. guided to be approximately 90.0% for FY 2025.

Invest in a chain of urgent care centers in key markets to establish a direct-to-consumer care delivery channel. This is a move into care delivery, a new service area that complements the existing Health Benefits segment revenue of $42.2 billion in Q3 2025. Direct ownership gives Elevance Health Inc. more control over cost trends, which is critical given the expected decline in Medicaid operating margin by at least 125 basis points year-over-year in 2026.

Form a joint venture with a major pharmaceutical company to develop and distribute specialty drugs, bypassing traditional pharmacy benefit managers (PBMs). This directly targets the PBM space where CarelonRx operates. The Carelon segment posted an operating gain of $0.8 billion in Q3 2025. Bypassing PBMs could significantly alter the cost structure for specialty drugs, which are a major driver of medical costs across the industry.

Enter the financial services market by offering health-linked credit products or specialized insurance for long-term care. This leverages the existing large member base, which was forecasted to include Medicare Advantage membership between 2.2 million and 2.25 million by the end of 2025. Offering credit products would create a new, non-premium revenue stream, supplementing the current quarterly dividend of $1.71 per share, which represents a dividend payout ratio of 27.96%.

Develop a data monetization service, selling anonymized population health insights to life sciences companies, generating $100 million in new revenue. This leverages the vast amount of data Elevance Health Inc. manages. This target revenue of $100 million represents about 0.05% of the TTM revenue of $194.820B, showing it's a small but incremental revenue stream that utilizes existing assets.

Here are some key financial metrics from the latest reported period for context:

Metric	Value (2025)	Period/Context
Operating Revenue (TTM)	$194.820B	Twelve Months ending September 30, 2025
Operating Revenue (Quarterly)	$50.1 billion	Third Quarter 2025
Adjusted Diluted EPS Guidance	Approximately $30.00	Full Year 2025
Carelon Segment Operating Revenue	$18.3 billion	Third Quarter 2025
Parent Company Cash & Investments	Approximately $2.6 billion	As of September 30, 2025
Quarterly Dividend Paid	$1.71	Third Quarter 2025

The strategic moves outlined require capital deployment, which Elevance Health Inc. has partially defined:

• Dividends: 20% of capital allocation
• Share Repurchases: 30% of capital allocation
• M&A and Organic Reinvestment: 50% of capital allocation

The success of these diversification efforts will ultimately be measured against the company's core performance, such as maintaining its adjusted diluted EPS growth target of at least 12% average annual growth over the long term. If onboarding takes 14+ days for new tech integration, churn risk rises.